Investing in Anika Therapeutics Inc. (ANIK)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)28.8215
Intrinsic value (DCF)31.0024
Graham-Dodd Method8.84-65
Graham Formula0.00-100

Company description

Anika Therapeutics Inc., with ticker symbol ANIK, is a leading global medical technology company that specializes in therapeutic treatments for joint pain and other painful medical conditions. The company is dedicated to improving the lives of patients through innovative and effective solutions. Founded in 1992 and headquartered in Massachusetts, ANIK has a strong presence in over 30 countries and a diverse product portfolio. Their flagship product, HYALGAN, is a highly successful treatment for osteoarthritis of the knee, and their other products include treatments for joint and wound pain, as well as regenerative therapies. ANIK is committed to advanced research and development, with a talented team of scientists and engineers constantly working towards creating new and improved solutions for patients. The company is driven by a strong business model, robust financial performance, and a clear vision to be a leader in the healthcare industry. With a strong customer base and a global reach, ANIK is well-positioned for continued success and growth in the future.